This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I)
wherein Y, L, Z, W, X, Q, R
1
, R
2
and R
3
are as defined in the specification.
Hitidentification in drug discovery is not always straightforward: A virtualscreening against Mycobacterium tuberculosis 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) did not result in a suitable on-target hit, but testing against pathogenic bacteria revealed promising growth inhibition of Gram-negative Escherichia coli of one compound class. Establishing a robust synthetic route made quick investigation
Novel-N-(4-(Aminosubstituted)phenyl) methanesulfonamides and their use as cardiovascular agents
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0332570A2
公开(公告)日:1989-09-13
Novel N-[4-aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents, especially as antiarrhythmic agents are described. Pharmaceutical formulations containing such compounds are also discussed.
[EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE DESACETYLASE
申请人:METHYLGENE INC
公开号:WO2006102760A1
公开(公告)日:2006-10-05
[EN] This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I); wherein Y, L, Z, W, X, Q, R1, R2 and R3 are as defined in the specification. [FR] L'invention concerne des composés inhibiteurs de l'histone-désacétylase. L'invention concerne en particulier des composés représentés par la formule (I) dans laquelle Y, L, Z, W, X, Q, R1, R2 et R3 sont tels que définis dans les spécifications.